1 unchanged sentence
The information required by Item 201 of Regulation S-K is contained in ‘‘ Item 1.
−Removed: On July 1, 2023, our Board made grants to our CEO and CFO, entitling them to receive an aggregate of 79,589 common shares which shall not be issued to the award recipients unless certain time or performance based vesting criteria, as applicable, are met, in which case the vesting will occur in three equal parts on the succeeding periods ending on July 1.
−Removed: The awards were made under the 2020 Equity Incentive plan in accordance with Rule 701 promulgated under the Securities Act.
−Removed: On July 3, 2023, our Board made grants to our directors entitling them to receive an aggregate of 64,975 common shares which shall not be issued to the award recipients unless certain time or performance based vesting criteria, as applicable, are met, in which case the vesting will occur in three equal parts on the succeeding periods ending on December 31.
+Added: On January 1, 2024, the Board of Directors made grants to our directors entitling them to an aggregate of 63,980 common shares which shall not be issued to the award recipients unless certain time based vesting criteria are met, in which case the vesting will occur in three equal parts on the succeeding periods ending on December 31.
The awards were made under the 2020 Equity Incentive plan in accordance with Rule 701 promulgated under the Securities Act.
−Removed: On December 31, 2023, our Board made grants to our management and employees entitling them to receive an aggregate of 213,982 common shares which shall not be issued to the award recipients unless certain time or performance based vesting criteria, as applicable, are met, in which case the vesting will occur in three equal parts on the succeeding periods ending on December 31.
+Added: On March 19, 2024, the Board authorized a new share repurchase program of up to 2,191,320 common shares, representing 10% of the outstanding common shares of the Company at such time, for an aggregate purchase price of not more than US $12.0 million.
+Added: The program was pursuant to a normal course issuer bid and was conducted in accordance with Rule 10b-18 under the Exchange Act.
+Added: The program commenced on March 27, 2024 and was set to expire March 26, 2025, unless the maximum amount of common shares is purchased before then or the Board approves earlier termination.
+Added: On February 12, 2025, the Board terminated and revoked authority under this share repurchase program.
+Added: On February 12, 2025, the Board authorized a new share repurchase program of up to 2,200,876 common shares, representing 10% of the outstanding common shares of the Company at such time, for an aggregate purchase price of not more than US $13.0 million.
+Added: The program is pursuant to a normal course issuer bid and conducted in accordance with Rule 10b-18 under the Exchange Act.
+Added: The program commenced on February 12, 2025 and is set to expire February 11, 2026, unless the maximum amount of common shares is purchased before then or the Board approves earlier termination.
+Added: On December 31, 2024, our Board made grants to our management, employees, and directors entitling them to receive an aggregate of 236,072 common shares which shall not be issued to the award recipients unless certain time based vesting criteria are met, in which case the vesting will occur in three equal parts on the succeeding periods ending on December 31.
The awards were made under the 2020 Equity Incentive plan in accordance with Rule 701 promulgated under the Securities Act.
−Removed: On March 9, 2023, the Board of Directors authorized a new share repurchase program of up to 2,292,644 common shares, representing 10% of the outstanding common shares of Epsilon at that time, for an aggregate purchase price of not more than US $15.0 million.
−Removed: The program is pursuant to a normal course issuer bid and will be conducted in accordance with Rule 10b-18 under the Exchange Act.
−Removed: The program commenced on March 27, 2023 and will end on March 26, 2024.
−Removed: The Company funded the purchases out of available cash and did not incur debt to fund the share repurchase program.
+Added: The Company funds the purchases out of available cash and does not incur debt to fund the share repurchase program.
The shares are accounted for as treasury shares until such a time as they are retired.
−Removed: The following table provides information with respect to the common share purchases made by the Company during the three months ended December 31, 2023.
−Removed: Total number of
−Removed: Maximum number
−Removed: shares purchased
−Removed: of shares that
−Removed: Average price
−Removed: purchased under
−Removed: announced plans
−Removed: December 2023
+Added: There were no common share purchases made by the Company during the three months ended December 31, 2024.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.